The Cancer Immunotherapy Consortium is governed by an executive committee who are tasked with further developing the Consortium's mission, choosing its priority projects, and monitoring the program's overall progress.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
An interview with bestselling author Charles Graeber about his new book, The Breakthrough: Immunotherapy and the Race to Cure Cancer.
Dr. Jill O’Donnell-Tormey participated in an expert panel discussion on rare cancers for The Forum at the Harvard T.H. Chan School of Public Health in February 2019.